Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Mass Spectrometry Market CAGR Outlook And Future Development
The mass spectrometry market has seen rapid expansion in recent years. It is projected to increase from $7.2 billion in 2025 to $7.93 billion in 2026, at a compound annual growth rate (CAGR) of 10.1%. This historical growth can be attributed to advancements in analytical chemistry techniques, the expansion of pharmaceutical and biotechnology research, more stringent regulatory testing requirements, the growth of academic and research laboratories, and an increasing need for precise molecular identification.
The mass spectrometry market size is forecasted for significant expansion in the upcoming years, with projections indicating a rise to $11.75 billion in 2030, achieving a compound annual growth rate (CAGR) of 10.3%. This growth during the forecast period can be attributed to an increase in clinical diagnostics applications, the enlargement of proteomics and metabolomics research, stricter food and environmental safety regulations, increased investments in life science research infrastructure, and a demand for high-throughput and accurate analytical instruments. Noteworthy trends for the forecast period include the expanding adoption of high-resolution and hybrid mass spectrometry systems, a rising need for mass spectrometry in clinical and diagnostic applications, its increased deployment in environmental and food safety testing, the broadening use of mass spectrometry in pharmaceutical quality control, and a growing preference for multi-application and modular mass spectrometry platforms.
Get A Free Sample Report With In-Depth Market Insights:
Mass Spectrometry Market Growth Factors: What’s Supporting Expansion?
The rising occurrence of chronic illnesses is anticipated to boost the expansion of the mass spectrometry market in the future. These conditions are defined as ailments typically persisting for three months or more, deteriorating progressively. Mass spectrometry methods are employed to identify, quantify, and analyze specific biomarkers and metabolites linked to chronic diseases. As an example, in April 2025, the Centers for Disease Control and Prevention, a US-based organization dedicated to safeguarding the nation from health, safety, and security risks through vital scientific research, disclosed that in 2023, 76.4% (equating to 194 million) of US adults indicated having 1 or more chronic conditions. This included 59.5% of young adults, 78.4% of midlife adults, and 93.0% of older adults, respectively. Consequently, the growing occurrence of chronic diseases is fueling the development of the mass spectrometry market.
Mass Spectrometry Market Segment Breakdown: Which Categories Lead On Revenue?
The mass spectrometry market covered in this report is segmented –
1) By Technology: Hybrid Mass Spectrometry, Single Mass Spectrometry, Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
2) By Application: Life Science Research, Drug Discovery, Environmental Testing, Food Testing, Applied Industries, Clinical Diagnostics, Other Applications
3) By End User: Pharmaceutical Industry, Biotechnology Industry, Research And Academic Institutes, Environmental Testing Industry, Food And Beverage Testing Industry, Petrochemical Industry, Other End Users
Subsegments:
1) By Hybrid Mass Spectrometry: Quadrupole Time-of-Flight (QTOF), Orbitrap Mass Spectrometry, Triple Quadrupole Mass Spectrometry
2) By Single Mass Spectrometry: Time-Of-Flight (TOF), Quadrupole Mass Spectrometry, Ion Trap Mass Spectrometry, Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
3) By Inductively Coupled Plasma Mass Spectrometry (ICP-MS): Quadrupole ICP-MS, Sector Field ICP-MS, High-Resolution ICP-MS
Mass Spectrometry Market Industry Trends: What’s Reshaping Demand?
Leading firms within the mass spectrometry sector are concentrating their efforts on creating sophisticated mass spectrometers, such as the Astral analyzer, to facilitate groundbreaking proteomic discoveries and secure a competitive advantage. This Astral analyzer represents cutting-edge mass spectrometry technology, distinguished by its rapid processing, exceptional sensitivity, and comprehensive proteome exploration capabilities. As an illustration, in June 2023, Thermo Fisher, an American supplier of analytical instruments, introduced the Orbitrap Astral mass spectrometer, marking a significant technological advance in the field. The Astral analyzer delivers swift sample processing, elevated sensitivity, and broad proteome coverage, empowering researchers to efficiently identify proteins that were previously undiscovered. This particular mass spectrometer facilitates the recognition of novel clinical biomarkers, aids in the early diagnosis of diseases, and supports the creation of treatments for diverse ailments such as cardiovascular disease and cancer. This innovation is founded upon Thermo Fisher’s existing Orbitrap mass spectrometry platform, offering up to two times greater depth in proteome coverage and up to four times increased throughput compared to existing spectrometers.
Mass Spectrometry Market Leading Players And Competitive Positioning
Major companies operating in the mass spectrometry market are Agilent Technologies Inc., Bruker Corporation, JEOL Ltd., LECO Corporation, PerkinElmer Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, AB Sciex Pte Ltd., Danaher Corporation, Hitachi Ltd., Rigaku Corporation, Advion Inc., AMETEK Inc., Analytik Jena GmbH, DANI Instruments S.p.A., Eurofins Scientific SE, MKS Instruments, Elementar Analysensysteme GmbH, Hiden Analytical Europe GmbH, SPECTRO Analytical Instruments GmbH, EXUM INSTRUMENTS INC., 908 Devices Inc., MassTech Inc., Newomics Inc., Microsaic Systems plc, SCIEX AB, Kore Technologies Ltd., IonSense Inc.
View The Full Mass Spectrometry Market Report:
Mass Spectrometry Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the mass spectrometry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the mass spectrometry market size forecast period. The regions covered in the mass spectrometry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









